Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Alzheimer's Disease

  Free Subscription


20.10.2025

1 Acta Neuropathol
17 Alzheimers Dement
1 Biol Psychiatry
1 Brain Res
2 Exp Neurol
6 J Alzheimers Dis
1 J Neurol
1 Nat Med
1 Nature
1 Neurobiol Dis
1 Neurology
1 Neuropsychology
2 Neuroscience
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. AUGUR ZM, Fogo GM, Arbery MR, Hsieh YC, et al
    Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasis.
    Acta Neuropathol. 2025;150:43.
    PubMed         Abstract available


    Alzheimers Dement

  2. YE R, Goodheart AE, Locascio JJ, Peterec EC, et al
    APOE epsilon4 linked effects on clinical features and neuropathology in dementia with Lewy bodies.
    Alzheimers Dement. 2025;21:e70795.
    PubMed         Abstract available

  3. JACOBS T, Brien CO, Figueredo L, Gogola A, et al
    Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70765.
    PubMed         Abstract available

  4. ROTBLATT LJ, Edwards L, Erani F, Terao CM, et al
    Impact of regional white matter hyperintensity patterns on cognitive trajectories in NACC.
    Alzheimers Dement. 2025;21:e70764.
    PubMed         Abstract available

  5. MANUILOVA E, Schrurs I, Rutz S, McIlwrick S, et al
    Elecsys CSF AD immunoassays: Sample stability for a new pre-analytical protocol for fresh CSF.
    Alzheimers Dement. 2025;21:e70797.
    PubMed         Abstract available


  6. Correction to "Natural language processing-based classification of early Alzheimer's disease from connected speech".
    Alzheimers Dement. 2025;21:e70827.
    PubMed        

  7. SANTIAGO-MEJIAS S, Hromas G, LaRoche A, Gonzalez DA, et al
    Addressing language challenges in bilingual neuropsychological assessments at the South Texas Alzheimer's Disease Research Center (ADRC).
    Alzheimers Dement. 2025;21:e70800.
    PubMed         Abstract available

  8. COLLIJ LE, Mattsson-Carlgren N, Janelidze S, Ossenkoppele R, et al
    Complementary utility of plasma biomarkers and Abeta-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70763.
    PubMed         Abstract available

  9. VROMEN EM, Lageman SB, Gobom J, van der Kant R, et al
    Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70738.
    PubMed         Abstract available

  10. SANTOS A, Almeida FC, Gauthreaux K, Mock CN, et al
    White matter microstructure is differentially impacted by cerebral amyloid angiopathy, neurofibrillary tangles, and neuritic plaque co-pathology.
    Alzheimers Dement. 2025;21:e70637.
    PubMed         Abstract available

  11. GREER RA, Tuckey RA, Dean HB, Brett TJ, et al
    TREM2-apoE3 interactions and Alzheimer's disease: Molecular and structural insights and effects of TREM2 R47H and apoE4 variants.
    Alzheimers Dement. 2025;21:e70729.
    PubMed         Abstract available

  12. SHIRZADI Z, Schultz AP, Loghmani N, Yang HS, et al
    Independent effects of white matter lesion volume and APOE varepsilon4 on ARIA-H in A4 Study.
    Alzheimers Dement. 2025;21:e70751.
    PubMed         Abstract available

  13. FISCHER DL, Grinberg LT, Ahrendsen JT, Beach TG, et al
    Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers.
    Alzheimers Dement. 2025;21:e70734.
    PubMed         Abstract available

  14. ZHU CW, Flournoy C, Raman R, Sano M, et al
    Employment, volunteering, and health-related resource use in pre-symptomatic AD: Results from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study.
    Alzheimers Dement. 2025;21:e70641.
    PubMed         Abstract available

  15. LORENZINI L, Tranfa M, Pieperhoff L, Masserini F, et al
    Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinning.
    Alzheimers Dement. 2025;21:e70762.
    PubMed         Abstract available

  16. BAUER A, Rabe C, Schiffman C, Rose F, et al
    Blood-based pre-screening in the SKYLINE secondary prevention Ph3 gantenerumab study.
    Alzheimers Dement. 2025;21:e70676.
    PubMed         Abstract available

  17. LI X, Fernandes BS, Liu A, Chen J, et al
    GRPa-PRS: A risk stratification method to identify genetically-regulated pathways in polygenic diseases.
    Alzheimers Dement. 2025;21:e70779.
    PubMed         Abstract available

  18. KOSA AC, Lopez-Gutierrez L, Ando K, Doeraene E, et al
    Differential effects of age and sex on tau pathology propagation in the htau mouse model: A neuropathological and proteomic study.
    Alzheimers Dement. 2025;21:e70784.
    PubMed         Abstract available


    Biol Psychiatry

  19. OPPENHEIMER H, Shadrin A, Andersen JO, Schindler LS, et al
    Investigating Shared Cardiovascular Factors and Genetic Overlap of Pregnancy-Related Disorders, Major Depressive Disorder, and Alzheimer's Disease.
    Biol Psychiatry. 2025 Oct 9:S0006-3223(25)01519.
    PubMed         Abstract available


    Brain Res

  20. VLACHOS I, Moschovos C, Apostolakopoulou L, Karasavvidou K, et al
    Resting EEG partial coherence demonstrates increased gamma range central functional connectivity in amnestic mild cognitive impairment.
    Brain Res. 2025;1867:149973.
    PubMed         Abstract available


    Exp Neurol

  21. KIM D, Shim K, Kim J, Ko G, et al
    Potential anti-amyloid beta oligomerization effects of PD166793 in Alzheimer's disease.
    Exp Neurol. 2025 Oct 13:115504. doi: 10.1016/j.expneurol.2025.115504.
    PubMed         Abstract available

  22. PANTIYA P, Chattipakorn N, Chattipakorn SC
    Exploring the role of CD147 in cerebrovascular and Alzheimer's pathologies: Insights into mechanisms and interventions.
    Exp Neurol. 2025;395:115498.
    PubMed         Abstract available


    J Alzheimers Dis

  23. KELSEY PT, Selbaek G, Lovheim H, Asvold BO, et al
    Helicobacter pylori and Alzheimer's disease risk: The HUNT study.
    J Alzheimers Dis. 2025 Oct 15:13872877251386015. doi: 10.1177/13872877251386015.
    PubMed         Abstract available

  24. BESSER LM, Baig M, Henriquez AM, Tolea M, et al
    Sociodemographic correlates of cognition and Alzheimer's disease and vascular biomarkers among middle to older age participants in the Healthy Brain Initiative.
    J Alzheimers Dis. 2025 Oct 15:13872877251386378. doi: 10.1177/13872877251386378.
    PubMed         Abstract available

  25. ARRIOLA-INFANTE JE, Garcia-Roldan E, Garcia-Solis D, Lojo-Ramirez JA, et al
    Alternative TMA-93 version demonstrates comparable performance and discriminative accuracy in early Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 16:13872877251386479. doi: 10.1177/13872877251386479.
    PubMed         Abstract available

  26. AIELLO EN, Gendarini C, Cocuzza A, Romandini A, et al
    Semantic and phonemic advantages in Alzheimer's disease and behavioral variant-frontotemporal dementia: Insights from the Fluency Type Index.
    J Alzheimers Dis. 2025 Oct 16:13872877251386438. doi: 10.1177/13872877251386438.
    PubMed         Abstract available

  27. ZOU M, Yu H, Zhou R, Lu Y, et al
    Association between dental floss use, dental visits, and a five-year Alzheimer's disease risk prediction score among United States adults aged 65 years and older.
    J Alzheimers Dis. 2025 Oct 16:13872877251386836. doi: 10.1177/13872877251386836.
    PubMed         Abstract available

  28. MUNOZ-MUSAT E, Le Prince G, Delmaire C, Paquet C, et al
    Cerebellar atrophy in biologically confirmed Alzheimer's disease: Associations with amyloidopathy measured by cerebrospinal fluid biomarkers.
    J Alzheimers Dis. 2025 Oct 17:13872877251386085. doi: 10.1177/13872877251386085.
    PubMed         Abstract available


    J Neurol

  29. HUANG XT, Huang LY, Tan CC, Wei JM, et al
    The role of APOE epsilon4 in modulating the relationship between non-genetic risk factors and dementia: a system review and meta-analysis.
    J Neurol. 2025;272:690.
    PubMed         Abstract available


    Nat Med


  30. A brief digital cognitive test improves Alzheimer's disease detection.
    Nat Med. 2025 Oct 16. doi: 10.1038/s41591-025-04024.
    PubMed        


    Nature

  31. FIELDHOUSE R
    Men's brains shrink faster than women's: what that means for Alzheimer's.
    Nature. 2025 Oct 13. doi: 10.1038/d41586-025-03353.
    PubMed        


    Neurobiol Dis

  32. YE Q, Gast G, Holmes TC, Xu X, et al
    Hippocampal neural circuit mechanisms in Alzheimer's disease revealed by viral-genetic circuits mapping.
    Neurobiol Dis. 2025 Oct 11:107139. doi: 10.1016/j.nbd.2025.107139.
    PubMed         Abstract available


    Neurology

  33. ONG JJH, Leow YJ, Qiu B, Tanoto P, et al
    Association of Enlarged Perivascular Spaces With Early Serum and Neuroimaging Biomarkers of Alzheimer Disease Pathology.
    Neurology. 2025;105:e214339.
    PubMed        


    Neuropsychology

  34. VAN DER LANDEN SM, Rhodius-Meester HFM, Postema MC, Jutten RJ, et al
    The relationship between cognitive domains and everyday functioning in Alzheimer's disease.
    Neuropsychology. 2025 Oct 16. doi: 10.1037/neu0001038.
    PubMed         Abstract available


    Neuroscience

  35. ELAMIN SA, Al Shibli AN, Shaito A, Al-Maadhadi MJMB, et al
    Anti-amyloid monoclonal antibody therapies in Alzheimer's disease - a scoping review.
    Neuroscience. 2025 Oct 10:S0306-4522(25)01003.
    PubMed         Abstract available

  36. ESCOBAR-LOPEZ M, Salazar-Varas R
    Analysis of EEG coherence according to the onset of Alzheimer's disease.
    Neuroscience. 2025 Oct 10:S0306-4522(25)00979.
    PubMed         Abstract available


    PLoS One

  37. HODGSON NA, Talwar S, Aryal S, Finegan K, et al
    Beyond single support calls: Efficacy of follow-up callbacks for dementia caregivers using the Alzheimer's association helpline.
    PLoS One. 2025;20:e0333535.
    PubMed         Abstract available

  38. TONG Q, Wu J, Jiao Q, Wu H, et al
    Global burden of Alzheimer's disease and other dementias attributable to smoking in 204 countries and territories, 1990-2021.
    PLoS One. 2025;20:e0334619.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  39. RAVNDAL A, Fjell AM, Vidal-Pineiro D, Sorensen O, et al
    Sex differences in healthy brain aging are unlikely to explain higher Alzheimer's disease prevalence in women.
    Proc Natl Acad Sci U S A. 2025;122:e2510486122.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.